Intravenous immunoglobulins: an eye opener on the successful treatment of severe adult-onset paraprotein-associated xanthogranulomatosis.

Bergqvist, C; Bernigaud, C; Ingen-Housz-Oro, S; Sujobert, P; Hotz, C; Lebre, C; Ortonne, N; Chosidow, O

Bergqvist, C; Bernigaud, C; Ingen-Housz-Oro, S; Sujobert, P; Hotz, C; Lebre, C; Ortonne, N; Chosidow, O.

Afiliação

Bergqvist C; Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.
Bernigaud C; Université Paris-Est Créteil, Créteil, France.
Ingen-Housz-Oro S; Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.
Sujobert P; Université Paris-Est Créteil, Créteil, France.
Hotz C; Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.
Lebre C; Department of Biological Haematology, Hôpital Lyon-sud, Pierre-Bénite, France.
Ortonne N; Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.
Chosidow O; Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.

Clin Exp Dermatol ; 46(7): 1346-1348, 2021 Oct.

Article em En | MEDLINE | ID: mdl-33969535

Assuntos

Imunoglobulinas Intravenosas/uso terapêutico; Pele/patologia; Xantomatose/terapia; Idoso; Humanos; Masculino; Pessoa de Meia-Idade; Paraproteínas; Xantomatose/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Xantomatose / Imunoglobulinas Intravenosas Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google